Your Messages Inbox
Your Article Summary
See Latest ArticlesBioMarin Supports Observance of Rare Disease Day February
BioMarin, 02/27/09
BioMarin Pharmaceutical Inc. announced that it will participate in a coalition of organizations led by the National Organization for Rare Disorders to support the observance of Rare Disease Day on February. A variety of patient organizations, professional societies, government agencies, medical researchers and biopharmaceutical companies will also participate in the campaign, which is designed to raise awareness about the public health issues associated with rare diseases, which affect nearly 30 million Americans and millions of others internationally.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Abbott to Acquire Novel Investigational Biologic to Treat Chronic Pain
Abbott, 11/16/09
Successful purchase of trait platform with extensive product pipeline
BayNews International, 11/06/09
Sanofi-aventis and US biopharmaceutical company Micromet sign global collaboration and license agreement for new solid tumor BiTE antibody
Sanofi-aventis, 10/30/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Dell Tries to Make an EHR Splash
HealthDataManagement, 11/03/09
Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline
Lundbeck, 11/02/09
Forest Laboratories, Inc. and Gedeon Richter Announce Positive Results from a Phase IIb Study of Cariprazine for the Treatment of Schizophrenia
Forest Laboratories, 10/29/09
Article Search
Sponsor